- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02120599
Interventions for Moderate Malnutrition in Pregnancy (Mamachiponde)
November 9, 2016 updated by: Washington University School of Medicine
Randomized Controlled Trial of the Impact of Treating Moderately Malnourished Women in Pregnancy
Malnutrition during pregnancy is more common in poor women in the developing world due to inadequate dietary intake combined with increased nutrient requirements; pregnancy risk is more consequential than among other demographic groups with increased risk of maternal and infant mortality and the lifelong effects of fetal malnutrition.
The benefits of treating moderate malnutrition during pregnancy remain largely undocumented.
This study tests the hypothesis that providing either a fortified flour or fortified paste-based supplementary food designed to replete the nutrient deficits during pregnancy will result in improved maternal nutritional recovery rates and higher infant birth weights and lengths.
This study is a randomized, controlled clinical trial of 3 supplementary foods in 1800 moderately malnourished Malawian women who are pregnant.
Subjects will receive one of 3 food rations: 1) a ready-to-use supplementary food formulated to deliver about 200% of the recommended daily allowance (RDA) of most micronutrients in pregnancy (RUSF-P), 2) corn soy blend with a multiple micronutrient tablet chosen to deliver about 200% of the RDA of most micronutrients (CSB-P) or 3), the standard of care which is a corn soy blend with supplementary iron and folic acid (CSB), delivering between 0-350% of the RDA.
Subjects will receive the supplementary food until they recover from MAM.
The outcome of the pregnancy and maternal nutritional status will be followed until 3 months after delivery.
Study Overview
Status
Completed
Conditions
Study Type
Interventional
Enrollment (Actual)
1867
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Blantyre, Malawi
- Blantyre District
-
Chikwawa, Malawi
- Chikwawa District
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Pregnant and consenting to study participation and HIV testing (if not already performed)
- mid-upper-arm circumference (MUAC) ≤ 23 cm
- planning to stay in the area and attend the clinic during pregnancy and for 3 months post partum
Exclusion Criteria:
- Pregnancy complications such as gestational diabetes, pre-eclampsia, hypertension
- Severe anemia (Hg <7.0 mg/dl)
- Severe malnutrition
- under 18 years of age
- over estimated 35 weeks of gestation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: corn-soy-blend
This is the control group for the study, which will receive the Malawi standard of care.
The treatment provided to women randomized to this arm of the study includes daily iron (60 mg) and folic acid (400 mcg) supplementation, along with 4 kg/2 weeks corn-soy blend (~357 gm/d CSB).
|
|
|
Experimental: corn-soy-blend + multiple micronutrients
The treatment provided to women randomized to this arm of the study includes 200gm/d CSB along with a standard maternal multiple micronutrient tablet, which together provide a comparable amount of energy, protein and micronutrients to the ready-to-use supplemental food.
The micronutrient supplement known as the United Nations Children's Emergency Fund (UNICEF) / World Health Organization (WHO) / United Nations University (UNU) international multiple micronutrient preparation (UNIMMAP) is widely available and has been used in many settings worldwide in pregnant women.
|
|
|
Experimental: ready-to-use supplementary food
RUSF-P (ready-to-use supplementary food) provides 750 kcal/d, 20 g protein/d, and 200% of RDA/d for most micronutrients during pregnancy (except for vitamins A, B3, folic acid, minerals iodine, magnesium, and calcium which will remain near 100%)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Proportion recovered from moderate acute malnutrition (MAM)
Time Frame: up to 40 weeks
|
proportion of women who reach mid-upper arm circumference (MUAC) > 23.5 cm for 2 consecutive visits
|
up to 40 weeks
|
|
Maternal change in mid-upper arm circumference (MUAC)
Time Frame: up to 40 weeks
|
average change in mid-upper-arm circumference
|
up to 40 weeks
|
|
infant birth weight
Time Frame: up to 40 weeks
|
mean birth weights of infants born to mothers in the study
|
up to 40 weeks
|
|
infant birth length
Time Frame: up to 40 weeks
|
mean birth length of infants born to women in the study
|
up to 40 weeks
|
|
premature delivery
Time Frame: up to 36 weeks
|
proportion of infants born prematurely
|
up to 36 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
maternal weight gain
Time Frame: up to 40 weeks
|
up to 40 weeks
|
|
|
maternal hemoglobin
Time Frame: 8 weeks
|
changes in average hemoglobin level
|
8 weeks
|
|
pregnancy complications
Time Frame: up to 40 weeks
|
rate of pregnancy complications
|
up to 40 weeks
|
|
infant weight at 3 months
Time Frame: 3 months
|
3 months
|
|
|
infant length at 3 months
Time Frame: 3 months
|
3 months
|
|
|
infant survival at 3 months
Time Frame: 3 months
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Kenneth Maleta, MBBS PhD, University of Malawi
- Principal Investigator: Chrissie Thakwalakwa, University of Malawi
- Study Chair: Mark J Manary, MD, Washington University in St. Louis; University of Malawi
- Study Director: Peggy C Papathakis, PhD, RD, California Polytechnic State University-San Luis Obispo
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2014
Primary Completion (Actual)
August 1, 2016
Study Completion (Actual)
August 1, 2016
Study Registration Dates
First Submitted
April 18, 2014
First Submitted That Met QC Criteria
April 18, 2014
First Posted (Estimate)
April 23, 2014
Study Record Updates
Last Update Posted (Estimate)
November 10, 2016
Last Update Submitted That Met QC Criteria
November 9, 2016
Last Verified
November 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 201401112
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pregnancy
-
Far Eastern Memorial HospitalCompletedCornual PregnancyTaiwan
-
Peking Union Medical College HospitalPeking Union Medical CollegeUnknownPregnancy | Pregnancy Related | Infant | Pregnancy Disease | Risk FactorChina
-
Kafrelsheikh UniversityNot yet recruitingEctopic PregnancyEgypt
-
Meir Medical CenterRecruiting
-
Bagcilar Training and Research HospitalRecruitingEctopic PregnancyTurkey (Türkiye)
-
MELISA Institute Genomics & Proteomics Research...RecruitingHealthy | Pregnancy | Early Pregnancy | Early Pregnancy Loss | ChildbirthChile
-
Ufuk UniversityNot yet recruitingPregnancy Complications | Pregnancy Loss | Pregnancy Preterm
-
Hadassah Medical OrganizationCompleted
-
Turku University HospitalUniversity of TurkuCompleted
-
Centre Hospitalier Universitaire de Saint EtienneCompletedProlonged PregnancyFrance
Clinical Trials on folic acid
-
Universität des SaarlandesCompletedthe Effect of MTHFR C677T on Folate MetabolismGermany
-
Fundacion para la Investigacion Biomedica del Hospital...Completed
-
EndocyteCompleted
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Universidade Federal de GoiasFederal University of São Paulo; Ministry of Health, Brazil; Goiania Municipal...Completed
-
Centro Universitario de TonaláNot yet recruitingDrug Abuse | GenotoxicityMexico
-
Università degli Studi dell'InsubriaUniversita di VeronaNot yet recruitingPolycystic Ovary Syndrome
-
Zhao gengliVifor PharmaCompletedIron Deficiency Anemia | Iron DeficiencyChina
-
Wageningen Centre for Food SciencesWageningen UniversityCompletedHealthy | Folate BioavailabilityNetherlands
-
The Hospital for Sick ChildrenDuchesnay Inc.Completed